Eyepoint Pharmaceuticals Inc (EYPT)

Oct 14, 2025

JPMorgan and Partners Manage Offering for EYPT - GuruFocus

Oct 14, 2025

Oct 14, 2025

EyePoint (EYPT) Launches $150 Million Public Share Offering - GuruFocus

Oct 14, 2025

Oct 14, 2025

EyePoint Pharmaceuticals (EYPT) Announces $150 Million Public Of - GuruFocus

Oct 14, 2025

Oct 14, 2025

EyePoint Pharma slips after announcing $150 mln stock offering - TradingView

Oct 14, 2025

Oct 14, 2025

EyePoint announces proposed public offering of common stock - MSN

Oct 14, 2025

Oct 14, 2025

EyePoint Pharmaceuticals launches $150 million public offering By Investing.com - Investing.com Canada

Oct 14, 2025

Oct 14, 2025

EyePoint’s DURAVYU advances to phase 3 trials for diabetic eye disease - Investing.com Australia

Oct 14, 2025

Oct 14, 2025

Eyepoint Pharmaceuticals stock falls after $150 million share offering - Investing.com

Oct 14, 2025

Oct 14, 2025

EyePoint Announces Proposed Public Offering of Common Stock - GlobeNewswire

Oct 14, 2025

Oct 14, 2025

Eyepoint Pharmaceuticals Inc files for mixed shelf size not disclosedSEC filing - MarketScreener

Oct 14, 2025

Oct 14, 2025

EyePoint Pharmaceuticals Launches Phase 3 DURAVYU Program - TipRanks

Oct 14, 2025

Oct 14, 2025

EyePoint (EYPT) Advances Duravyu Phase 3 Program for Diabetic Ma - GuruFocus

Oct 14, 2025

Oct 14, 2025

Eyepoint Pharmaceuticals announces Phase 3 diabetes program starting in 2026 - Traders Union

Oct 14, 2025

Oct 14, 2025

EyePoint Pharmaceuticals Advances DURAVYU to Phase 3 Trials for Diabetic Macular Edema and Wet AMD, First Patient Dosing Expected in Q1 2026 - Quiver Quantitative

Oct 14, 2025

Oct 14, 2025

Chart based analysis of EyePoint Pharmaceuticals Inc. trendsJuly 2025 Big Picture & Technical Pattern Recognition Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

Is EyePoint Pharmaceuticals Inc. stock ready for breakoutRate Cut & Safe Capital Growth Stock Tips - newser.com

Oct 14, 2025

Oct 14, 2025

Will EyePoint Pharmaceuticals Inc. stock split attract more investorsJuly 2025 PostEarnings & Verified Chart Pattern Signals - newser.com

Oct 14, 2025

Oct 14, 2025

Will earnings trigger a reversal in EyePoint Pharmaceuticals Inc.Rate Hike & Precise Swing Trade Entry Alerts - newser.com

Oct 14, 2025

Oct 13, 2025

What does recent volatility data suggest for EyePoint Pharmaceuticals Inc.July 2025 Macro Moves & Intraday High Probability Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

EyePoint initiated at buy by Citi on wAMD drug potential - MSN

Oct 13, 2025

Oct 13, 2025

Using R and stats models for EyePoint Pharmaceuticals Inc. forecastingQuarterly Earnings Report & Risk Managed Investment Strategies - newser.com

Oct 13, 2025

Oct 10, 2025

Is EyePoint Pharmaceuticals Inc. (PV3B) stock a buy before new product rolloutExit Point & Momentum Based Trading Ideas - newser.com

Oct 10, 2025

Oct 10, 2025

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat

Oct 10, 2025

Oct 09, 2025

Eyepoint Pharmaceuticals' (EYPT) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 06, 2025

How EyePoint Pharmaceuticals Inc. (PV3B) stock behaves in tightening cyclesVolume Spike & Advanced Technical Signal Analysis - newser.com

Oct 06, 2025

Oct 06, 2025

Is a relief rally coming for EyePoint Pharmaceuticals Inc. holdersJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

What downside risks could hit EyePoint Pharmaceuticals Inc. (PV3B) stock2025 Market Trends & Low Drawdown Investment Ideas - newser.com

Oct 05, 2025

Oct 05, 2025

Using Bollinger Bands to evaluate EyePoint Pharmaceuticals Inc.2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com

Oct 05, 2025

Oct 05, 2025

What analysts say about EyePoint Pharmaceuticals Inc stockReal-Time Stock Alerts & Take Advantage of Momentum Stocks - earlytimes.in

Oct 05, 2025

Oct 03, 2025

EyePoint Pharmaceuticals Hits New 52-Week High of $14.90 - Markets Mojo

Oct 03, 2025

Oct 03, 2025

Can EyePoint Pharmaceuticals Inc. (PV3B) stock sustain margin levelsCEO Change & Daily Stock Trend Reports - newser.com

Oct 03, 2025

Oct 03, 2025

Candlestick signals on EyePoint Pharmaceuticals Inc. stock todayQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com

Oct 03, 2025

Oct 03, 2025

Published on: 2025-10-03 02:01:33 - newser.com

Oct 03, 2025

Oct 02, 2025

Sentiment analysis tools applied to EyePoint Pharmaceuticals Inc.Trade Volume Summary & Low Drawdown Momentum Ideas - newser.com

Oct 02, 2025

Oct 02, 2025

Mizuho Securities Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛

Oct 02, 2025

Oct 02, 2025

EyePoint stock rating reiterated at Outperform by Mizuho amid competitor review - Investing.com

Oct 02, 2025

Oct 01, 2025

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Hits New 1-Year HighHere's Why - MarketBeat

Oct 01, 2025

Sep 30, 2025

EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com

Sep 30, 2025

Sep 30, 2025

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Up 4%Time to Buy? - MarketBeat

Sep 30, 2025

Sep 29, 2025

Detecting support and resistance levels for EyePoint Pharmaceuticals Inc.July 2025 Market Mood & Momentum Based Trading Ideas - newser.com

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 08:12:16 - newser.com

Sep 29, 2025